# FDA Inspection 1256154 - Biomat USA, Inc. - November 12, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/aa4eb704-521c-4e6b-84c4-7f2ca0d7c64c
Source feed: FDA_Inspections

> FDA Inspection 1256154 for Biomat USA, Inc. on November 12, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256154
- Company Name: Biomat USA, Inc.
- Inspection Date: 2024-11-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1256154 - 2024-11-12](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/aa37f424-2591-4b6e-8285-d27001953909)
- [FDA Inspection 1071897 - 2018-11-14](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/51d03358-9802-48dc-8dee-3f7dee7b4a73)
- [FDA Inspection 680714 - 2010-09-21](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/4e4f56fd-5a4d-4a48-af70-48c8c9f0e95b)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/f0b48bee-57b8-440e-aa08-5fcb95961927

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d